Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer age

Details Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer age Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer age

1997-11-06

1999-06-01

Bernhardt, Emily

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514267, 540600, 544252, A61K 31505, A61K 3155, C07D47104

Patent

active

059088400

ABSTRACT:
This invention provides a compound having the formula: ##STR1## wherein: (A) n=2-4;

REFERENCES:
patent: 4033961 (1977-07-01), Schwender et al.
patent: 4104389 (1978-08-01), Schwender et al.
patent: 4348396 (1982-09-01), Kierstead et al.
Denny et al., Structure-activity relationships for the mutagenic activity of tricyclic intercalating agents in Selmonella typhimurium, Mutation Research, 232(1990) p. 233.
Ebeid et al., Synthesis and Antitumor Activity of Some N(p-Substituted Sulfamoylphenyl) Acridone-4-Carboxamides and N(p-substituted Egypt.J.Pharm Sci., vol. 33, No. 1-2, pp. 293-303 (1992).

Affiliated with

Also associated with

Rating

Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer age does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer age will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-955053